-+ 0.00%
-+ 0.00%
-+ 0.00%

GOSSAMER BIO, - UP TO $100 MLN ADDITIONAL FUNDING UPON FDA APPROVAL OF SERALUTINIB

路透·08/21/2026 12:00:00

登录查看新闻详情